van
loon
verheij
tjm
coenjaert
fej
behalf
grace
consortium
affili
abstract
object
studi
determin
associ
respiratori
virus
subsequ
ill
cours
primari
care
adult
patient
present
acut
cough
andor
suspect
lower
respiratori
tract
infect
lrti
method
prospect
european
primari
care
studi
recruit
adult
symptom
lower
respiratori
tract
infect
novapr
realtim
inhous
polymeras
chain
reaction
pcr
perform
test
six
common
respiratori
virus
secondari
analysi
symptom
sever
score
problem
symptom
durat
compar
group
differ
viral
aetiolog
use
regress
cox
proport
hazard
model
respect
addit
associ
baselin
viral
load
cycl
threshold
ct
valu
ill
cours
assess
result
pcr
test
posit
common
respiratori
viru
includ
patient
overal
mean
symptom
score
present
ci
median
durat
resolut
moder
bad
sever
symptom
day
interquartil
rang
patient
influenza
viru
human
metapneumoviru
hmpv
respiratori
syncyti
viru
rsv
coronaviru
cov
rhinoviru
significantli
higher
symptom
score
patient
viru
isol
point
higher
symptom
score
time
symptom
resolut
longer
rsv
infect
adjust
hazard
ratio
ahr
ci
hmpv
infect
ahr
ci
infect
viru
isol
overal
baselin
viral
load
associ
symptom
sever
differ
ci
per
cycl
decreas
ct
valu
symptom
durat
conclus
healthi
work
adult
gener
commun
present
gener
practition
acut
cough
andor
suspect
lrti
respiratori
virus
influenza
impos
ill
burden
compar
influenza
henc
public
health
focu
viral
respiratori
tract
infect
broaden
sputum
product
short
breath
wheez
block
runni
nose
fever
chest
pain
muscl
ach
headach
disturb
sleep
feel
gener
unwel
interfer
normal
daili
activ
addit
symptom
confusiondisorient
diarrhoea
rate
follow
initi
present
patient
ask
fill
symptom
diari
home
daili
basi
symptom
end
followup
day
patient
ask
rate
symptom
use
likertscal
littl
problem
problem
bad
bad
bad
could
diari
intern
reliabl
valid
sensit
chang
acut
lrti
nucleic
acid
amplif
test
multipathogen
extern
qualiti
assess
panel
j
clin
microbiol
bruyndonckx
r
stuart
b
littl
p
hen
n
ieven
butler
cc
et
al
amoxicillin
acut
lower
respiratori
tract
infect
primari
care
subgroup
analysi
bacteri
viral
aetiolog
clin
microbiol
infect
teep
j
littl
p
elshof
n
broekhuizen
bdl
moor
stuart
b
et
al
amoxicillin
clinic
unsuspect
pneumonia
primari
care
subgroup
analysi
studi
describ
aetiolog
acut
lower
respiratori
tract
infect
lrti
primari
care
patient
know
lrti
gener
commun
caus
viral
pathogen
particular
rhinoviru
influenza
viru
coronaviru
cov
respiratori
syncyti
viru
rsv
human
metapneumoviru
hmpv
parainfluenza
viru
piv
ill
cours
lrti
adult
present
set
rel
healthi
work
popul
mostli
limit
complic
rare
howev
averag
day
sick
leav
per
year
lrti
caus
substanti
socioeconom
burden
adult
influenza
viru
bacteria
viralbacteri
coinfect
assum
caus
sever
ill
system
symptom
longest
ill
durat
complic
howev
evid
associ
aetiolog
sever
mainli
deriv
hospit
care
set
vulner
patient
popul
set
focu
pathogen
highest
complic
rate
obviou
quit
often
howev
focu
also
appli
gener
commun
public
health
intervent
annual
influenza
vaccin
target
vulner
peopl
aim
reduc
risk
complic
death
although
data
impact
respiratori
virus
primari
care
set
limit
due
restrict
microbi
test
absenc
standard
valid
outcom
measur
evalu
ill
sever
studi
suggest
burden
diseas
infect
due
respiratori
virus
influenza
ip
rhinoviru
coronaviru
rsv
may
greater
overal
studi
aim
explor
associ
respiratori
viral
pathogen
includ
viral
load
ill
cours
adult
primari
care
commun
therebi
open
possibl
base
public
health
focu
impact
respiratori
virus
primari
care
rather
extrapol
data
hospit
set
studi
conduct
prospect
studi
primari
care
part
grace
studi
genom
combat
novemb
april
gener
practition
gp
primari
care
network
european
countri
supplementari
figur
patient
age
year
present
acut
cough
durat
day
andor
suspect
lrti
ask
particip
studi
ie
fill
studi
materi
provid
written
inform
consent
exclus
criteria
pregnanc
breastfeed
seriou
immunocompromis
condit
antibiot
use
previou
month
one
third
patient
agre
randomis
either
intervent
amoxicillin
placebo
arm
origin
random
control
trial
remain
patient
randomli
assign
includ
observ
part
studi
current
studi
trial
observ
patient
analys
togeth
patient
without
pcr
andor
serolog
result
viral
aetiolog
due
practic
reason
exclud
ethic
approv
obtain
particip
network
clinic
measur
collect
clinic
data
day
present
baselin
standard
case
report
form
crf
use
gp
complet
crf
follow
symptom
rate
patient
use
likertscal
problem
cough
baselin
two
nasopharyng
flock
swab
taken
train
staff
within
hour
recruit
antimicrobi
treatment
start
swab
place
univers
transport
medium
immedi
frozen
local
transport
dri
ice
central
laboratori
perform
either
four
multiplex
rsv
detect
frequent
symptomat
patient
control
consid
pathogen
respiratori
virus
therefor
exclud
analys
cycl
threshold
ct
valu
invers
logarithm
quantit
measur
viral
load
chosen
cutoff
posit
result
adjust
analys
bacteri
infect
defin
least
one
follow
pathogen
detect
sputum
nasopharyng
sampl
streptococcu
speci
gramneg
speci
aspergillu
fungu
commens
candida
speci
consid
contamin
analys
adjust
microbiologist
determin
result
blind
clinic
inform
outcom
paramet
focus
two
main
outcom
paramet
symptom
sever
present
ill
durat
symptom
sever
measur
mean
crf
score
symptom
score
baselin
ill
durat
defin
durat
absenc
symptom
rate
moder
bad
sever
score
symptom
diari
follow
initi
symptom
sever
baselin
analys
linear
regress
model
express
differ
mean
symptom
sever
confid
interv
ci
addit
step
present
ci
respiratori
virus
tabl
among
patient
viru
detect
ten
cycl
lower
ct
valu
ie
higher
viral
load
measur
present
associ
ci
point
higher
mean
symptom
sever
compar
patient
without
detect
viru
stratif
viral
aetiolog
observ
associ
viral
load
symptom
sever
rhinoviru
increas
per
cycl
reduct
ct
valu
ci
rsv
increas
per
cycl
symptom
virus
figur
influenza
viru
independ
associ
sever
gener
unwel
ci
interfer
daili
activ
ci
rsv
associ
sever
headach
ci
disturb
sleep
ci
runni
nose
ci
hmpv
associ
sever
dyspnoea
ci
headach
ci
rhinoviru
associ
sever
wheez
ci
runni
nose
ci
neg
associ
sever
cough
ci
cov
associ
final
higher
viral
load
associ
higher
symptom
sever
present
look
specif
virus
found
associ
rsv
rhinoviru
confirm
previou
techniqu
also
rise
drop
rapidli
known
symptom
mostli
follow
viral
load
conclus
studi
among
rel
healthi
adult
patient
present
primari
care
